BACKGROUND: Cancer survivors may experience posttraumatic growth (PTG), positive psychological changes resulting from highly stressful events; however, the longitudinal course of PTG is poorly understood. PURPOSE: The purpose of the present study was to determine trajectories of PTG in breast cancer survivors and associated characteristics. METHODS: Women (N = 653) participating in a longitudinal observational study completed questionnaires within 8 months of breast cancer diagnosis and 6, 12, and 18 months later. Group-based modeling identified PTG trajectories. Chi-square tests and ANOVA detected group differences in demographic, medical, and psychosocial variables. RESULTS: Six trajectory groups emerged. Three were stable at different levels of PTG, two increased modestly, and one increased substantially over time. Trajectory groups differed by age, race, receipt of chemotherapy, illness intrusiveness, depressive symptoms, active-adaptive coping, and social support. CONCLUSIONS: This first examination of PTG trajectories in US cancer survivors elucidates heterogeneity in longitudinal patterns of PTG. Future research should determine whether other samples exhibit similar trajectories and whether various PTG trajectories predict mental and physical health outcomes.
BACKGROUND:Cancer survivors may experience posttraumatic growth (PTG), positive psychological changes resulting from highly stressful events; however, the longitudinal course of PTG is poorly understood. PURPOSE: The purpose of the present study was to determine trajectories of PTG in breast cancer survivors and associated characteristics. METHODS:Women (N = 653) participating in a longitudinal observational study completed questionnaires within 8 months of breast cancer diagnosis and 6, 12, and 18 months later. Group-based modeling identified PTG trajectories. Chi-square tests and ANOVA detected group differences in demographic, medical, and psychosocial variables. RESULTS: Six trajectory groups emerged. Three were stable at different levels of PTG, two increased modestly, and one increased substantially over time. Trajectory groups differed by age, race, receipt of chemotherapy, illness intrusiveness, depressive symptoms, active-adaptive coping, and social support. CONCLUSIONS: This first examination of PTG trajectories in US cancer survivors elucidates heterogeneity in longitudinal patterns of PTG. Future research should determine whether other samples exhibit similar trajectories and whether various PTG trajectories predict mental and physical health outcomes.
Authors: M Hanson Frost; V J Suman; T A Rummans; A M Dose; M Taylor; P Novotny; R Johnson; R E Evans Journal: Psychooncology Date: 2000 May-Jun Impact factor: 3.894
Authors: Wendy W T Lam; George A Bonanno; Anthony D Mancini; Samuel Ho; Miranda Chan; Wai Ka Hung; Amy Or; Richard Fielding Journal: Psychooncology Date: 2010-10 Impact factor: 3.894
Authors: Nancy E Avis; Beverly Levine; Michelle J Naughton; L Douglas Case; Elizabeth Naftalis; Kimberly J Van Zee Journal: Breast Cancer Res Treat Date: 2013-04-16 Impact factor: 4.872
Authors: Sharon Manne; Jamie Ostroff; Gary Winkel; Lori Goldstein; Kevin Fox; Generosa Grana Journal: Psychosom Med Date: 2004 May-Jun Impact factor: 4.312
Authors: Abigail C Jones; Rachel Hilton; Blair Ely; Lovemore Gororo; Valerie Danesh; Carla M Sevin; James C Jackson; Leanne M Boehm Journal: Am J Crit Care Date: 2020-11-01 Impact factor: 2.228
Authors: Nik Ruzyanei Nik Jaafar; Nur Amirah Hamdan; Norhaliza Abd Hamid; Rama Krsna Rajandram; Raynuha Mahadevan; Hazli Zakaria; Mohd Razif Mohamad Yunus; Mohammad Farris Iman Leong Bin Abdullah Journal: PLoS One Date: 2022-03-15 Impact factor: 3.240
Authors: Chengshuai Zhang; Ruitong Gao; Jiandong Tai; Yuewei Li; Si Chen; Lei Chen; Xiaobai Cao; Li Wang; Minghua Jia; Feng Li Journal: Biomed Res Int Date: 2019-09-12 Impact factor: 3.411